Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)

    NIH's limited competition supports expansion and sustainability of biomedical research centers at eligible institutions in states with historically low NIH funding; clinical trials are not allowed.

    Browse similar grants
    Early Career Research Grants for New Faculty
    OverviewSimilar Grants
    OverviewSimilar Grants

    Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

    NIH's limited competition supports institutions in historically underfunded states to build biomedical research capacity through early-career recruitment, mentoring, facilities, and administrative support.

    HHS-NIH11Due Jan 25, 2027$7,600,000Limited submission

    IDeA Networks of Biomedical Research Excellence (INBRE)

    This grant funds statewide networks in underfunded states to build biomedical research capacity, support faculty and students, and enhance institutional infrastructure and collaboration.

    HHS-NIH11Forecasted May 18, 2027Forecasted

    Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

    NIH's limited competition supports clinical and translational research workforce and infrastructure development in states that have historically received low levels of NIH funding.

    HHS-NIH11Due Jan 28, 2027$17,000,000Limited submission

    Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

    This grant funds the construction or modernization of shared biomedical and HIV/AIDS research facilities to support collaborative, interdisciplinary research and strengthen national research capacity.

    HHS-NIH11Due Jan 25, 2027$8,000,000

    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

    NCI funds cancer research centers for 2027–2029 to advance prevention, detection, diagnosis, and treatment through translational research reaching a human endpoint; a clinical trial is required.

    HHS-NIH11Due Jan 25, 2027$7,600,000